Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy

  • Linden-Castro E
  • Pelayo-Nieto M
  • Alias-Melgar A
  • et al.
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Transrectal ultrasound-guided core prostate biopsy is a key event in the diagnosis of prostate cancer, transient side events such as local pain, haematuria, haematospermia, dysuria, and rectal bleeding are reported in a large number of patients. Antimicrobial agents lower the incidence of postbiopsy infectious complications. The timing and duration of the regimen and the route of administration remain controversial. We developed a standard prophylactic regimen, in which safety and efficiency were maximized, while costs and variability were minimized. Accordingly we prospectively evaluated 425 consecutive patients, who underwent outpatient transrectal ultrasound-guided prostate biopsy after a single dose versus three doses of levofloxacin.

Cite

CITATION STYLE

APA

Linden-Castro, E., Pelayo-Nieto, M., Alias-Melgar, A., & Carreño-de la Rosa, F. (2014). Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy. International Scholarly Research Notices, 2014, 1–4. https://doi.org/10.1155/2014/875670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free